Patents by Inventor Gregory Stauber

Gregory Stauber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Opiate receptor ligands
    Patent number: 5536853
    Abstract: Compounds of Formula 1 bind opioid receptors: ##STR1## wherein X and Y are each independently ##STR2##
    Type: Grant
    Filed: April 11, 1994
    Date of Patent: July 16, 1996
    Assignee: Chiron Corporation
    Inventors: David C. Spellmeyer, Walter H. Moos, Eric J. Martin, Ronald N. Zuckermann, Gregory Stauber, Kevin R. Shoemaker, Dane Goff
  • Peptoid .alpha.-1 adrenergic receptor ligands
    Patent number: 5480871
    Abstract: Compounds of the formula: ##STR1## are useful for treating conditions modulated by .alpha..sub.1 -adrenergic receptors.
    Type: Grant
    Filed: May 12, 1995
    Date of Patent: January 2, 1996
    Assignee: Chiron Corporation
    Inventors: David C. Spellmeyer, Walter H. Moos, Eric J. Martin, Ronald N. Zuckermann, Gregory Stauber
  • Peptoid alpha-1 adrenergic receptor ligands
    Patent number: 5447916
    Abstract: Compounds of the formula: ##STR1## are useful for treating conditions modulated by .alpha..sub.1 -adrenergic receptors.
    Type: Grant
    Filed: July 30, 1993
    Date of Patent: September 5, 1995
    Assignee: Chiron Corporation
    Inventors: David C. Spellmeyer, Walter H. Moos, Eric J. Martin, Ronald N. Zuckermann, Gregory Stauber